The enrichment of these inflammatory pathways in TMEM106A‐high gliomas suggests that TMEM106A expression is tightly linked to an inflammatory tumor microenvironment, characterized by cytokine activity and macrophage‐driven signaling networks. The gene discussed is TMEM106A; the disease is central nervous system cancer.